ADVERTISEMENT

prognostic indicators

Research in Review

Five-Factor Risk Assessment Identifies Patients Who Most Benefit from Bevacizumab Treatment

12/23/2015

JCP Editors

Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....

Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....

...

12/23/2015

Journal of Clinical Pathways

Research in Review

New MRI Technique Non-invasively Detects Biomarker for Lung Cancer

12/11/2015

JCP Editors

Researchers from Georgia State University, Atlanta, have developed a new imaging technique to better track cancer progression of the lung and prostate, according to a study published in Scientific Reports. The team,...

Researchers from Georgia State University, Atlanta, have developed a new imaging technique to better track cancer progression of the lung and prostate, according to a study published in Scientific Reports. The team,...

...

12/11/2015

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22

AMP Europe

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

Advertisement

Advertisement